PROSIGHT CAPITAL
PROSIGHT MANAGEMENT, LP Legal Name
Adviser information for PROSIGHT CAPITAL last updated from Form ADV on March 27th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
| Type of Organization | Limited Partnership |
|---|---|
| Fiscal Year End | DECEMBER |
| Legal Location | Delaware, United States |
Employees
| Total Number of Employees | 5 |
|---|---|
| Investment Advisory/Research | 5 |
| Registered Broker-Dealer Representatives | 0 |
| Registered State Investment Advisers | 1 |
| Licensed Agents of an Insurance Company | 0 |
| No. of Firms/People that Solicit Clients | 0 |
RAUM
| Provides Management of Securities Portfolios | Yes |
|---|
| Type | Accounts | RAUM |
|---|---|---|
| Discretionary | 6 | $658.7M |
| Non-Discretionary | 0 | $0 |
| Total | 6 | $658.7M |
Clients
| Type | Number | RAUM |
|---|---|---|
| Individuals | 0 | $0 |
| HNW Individuals | 0 | $0 |
| Banking or thrift institutions | 0 | $0 |
| Investment companies | 0 | $0 |
| Business development companies | 0 | $0 |
| Pooled investment vehicles | 6 | $658.7M |
| Pension and profit sharing plans | 0 | $0 |
| Charitable organizations | 0 | $0 |
| State or municipal gov entities | 0 | $0 |
| Other investment advisers | 0 | $0 |
| Insurance companies | 0 | $0 |
| Sovereign wealth funds and foreign official institutions | 0 | $0 |
| Corporations or other businesses | 0 | $0 |
| Other | 0 | $0 |
| Type | Number |
|---|---|
| No. of Non-RAUM Clients | 0 |
| No. of Non-U.S. Clients | 67 |
Services
| Advisory Services | Portfolio management for pooled investment vehicles |
|---|---|
| Compensation | % of AUMPerformance-based fees |
Principal Office
5956 SHERRY LANESUITE 1365
DALLAS
TX
United States
Monday - Friday, 8:00-5:00
Tel: (214) 468-0008, Fax: None
Websites
Chief Compliance Officer
RYAN M. CAPPELLI
CHIEF OPERATING OFFICER
5956 SHERRY LANE
SUITE 1365
DALLAS
TX
United States
Tel:
(214) 468-0008
R********@******************M
(Full email address available in API data)
Industry Affiliates
| None |
Private Funds
| Name | Type | Assets $USD | Min Investment $USD | No. Owners |
|---|---|---|---|---|
| PROSIGHT FUND, LP | Hedge Fund | $76.9M | $1.0M | 29 |
| PROSIGHT PLUS FUND, LP | Hedge Fund | $178.5M | $1.0M | 10 |
Control Persons
| Name | Type | Entity | Title | Since | Ownership |
|---|---|---|---|---|---|
| HAWKINS, WILLIAM, LAWRENCE | Individual | – | SOLE MEMBER / MANAGING PARTNER | 10/2008 | > 75% |
| PROSIGHT PARTNERS, LLC | Domestic Entity | – | GENERAL PARTNER OF PROSIGHT MANAGEMENT, LP | 11/2008 | < 5% |
| HAWKINS, WILLIAM, LAWRENCE | Individual | PROSIGHT PARTNERS LLC | SOLE MEMBER OF PROSIGHT PARTNERS LLC | 11/2008 | > 75% |
| CAPPELLI, RYAN, MATTHEW | Individual | – | CHIEF COMPLIANCE OFFICER / CHIEF OPERATING OFFICER | 06/2016 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
| Name | Class | Value $USD | # Shares | Private Fund |
|---|---|---|---|---|
| 10X GENOMICS INC | CL A COM | 953K | 49K | – |
| ABCELLERA BIOLOGICS INC | COM | 7M | 2M | – |
| ACCOLADE INC | COM | 5M | 1M | – |
| ADC THERAPEUTICS SA | SHS | 30M | 10M | – |
| ADDUS HOMECARE CORP | COM | 1M | 13K | – |
| AILERON THERAPEUTICS INC | COM NEW | 734K | 265K | – |
| ALKERMES PLC | SHS | 7M | 275K | – |
| BIOCRYST PHARMACEUTICALS INC | COM | 2M | 399K | – |
| BIOMEA FUSION INC | COM | 560K | 124K | – |
| BRIDGEBIO PHARMA INC | COM | 20M | 800K | – |
| COGENT BIOSCIENCES INC | COM | 4M | 500K | – |
| CVS HEALTH CORP | COM | 2M | 40K | – |
| CYTOKINETICS INC | COM NEW | 12M | 230K | – |
| DEXCOM INC | COM | 6M | 49K | – |
| ERASCA INC | COM | 6M | 3M | – |
| GALAPAGOS NV | SPON ADR | 33M | 1M | – |
| IMMUNEERING CORP | CLASS A COM | 704K | 550K | – |
| IMMUNOME INC | COM | 787K | 65K | – |
| IMMUNOVANT INC | COM | 9M | 325K | – |
| INSPIRE MED SYS INC | COM | 2M | 14K | – |
| KELLY SVCS INC | CL A | 11M | 492K | – |
| KEZAR LIFE SCIENCES INC | COM | 34K | 56K | – |
| KURA ONCOLOGY INC | COM | 13M | 630K | – |
| LENZ THERAPEUTICS INC | COM | 1M | 60K | – |
| MEDTRONIC PLC | SHS | 2M | 30K | – |
| MEIRAGTX HLDGS PLC | COM | 18M | 4M | – |
| MIRUM PHARMACEUTICALS INC | COM | 11M | 315K | – |
| MURAL ONCOLOGY PUB LTD CO | ORD SHS | 1M | 475K | – |
| NEUROCRINE BIOSCIENCES INC | COM | 4M | 27K | – |
| OPTION CARE HEALTH INC | COM NEW | 6M | 205K | – |
| ORTHOPEDIATRICS CORP | COM | 6M | 200K | – |
| OVID THERAPEUTICS INC | COM | 827K | 1M | – |
| PARAGON 28 INC | COM | 2M | 261K | – |
| PRIVIA HEALTH GROUP INC | COM | 2M | 96K | – |
| PROTHENA CORP PLC | SHS | 6M | 287K | – |
| RELAY THERAPEUTICS INC | COM | 3M | 385K | – |
| ROIVANT SCIENCES LTD | SHS | 21M | 2M | – |
| SCHRODINGER INC | COM | 7M | 369K | – |
| SHATTUCK LABS INC | COM | 18M | 5M | – |
| SYNDAX PHARMACEUTICALS INC | COM | 11M | 552K | – |
| TECTONIC THERAPEUTIC INC | COM | 1M | 67K | – |
| UNIVERSAL HLTH SVCS INC | CL B | 2M | 9K | – |
| VIKING THERAPEUTICS INC | COM | 6M | 115K | – |
| VINCERX PHARMA INC | COM NEW | 2M | 2M | – |
| ZIMMER BIOMET HOLDINGS INC | COM | 18M | 170K | – |
| ZYMEWORKS INC | COM | 10M | 1M | – |